National Research Corporation (NRC) vs SOPHiA GENETICS SA (SOPH)
National Research Corporation and SOPHiA GENETICS SA are both Health Information Services companies. SOPHiA GENETICS SA is the larger, with a market value of $703.2M against $450.1M — 1.6× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 78.3×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 23.7% against −0.23%. National Research Corporation has the higher net margin (3.96% vs −93.9%) and the higher return on invested capital (10.3% vs −196.5%). Across the 19 metrics below, National Research Corporation leads on 10 and SOPHiA GENETICS SA on 9.
Valuation
Profitability
| Metric | NRC | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 61.75% | 66.63% | 63.38% |
| Operating margin | 10.53% | (85.55%) | (8.35%) |
| Net margin | 3.96% | (93.86%) | (14.70%) |
| Free cash flow margin | 15.46% | (47.83%) | 0.58% |
| Return on equity | 39.82% | (101.22%) | (6.82%) |
| Return on assets | 4.00% | (43.02%) | (6.02%) |
| Return on invested capital | 10.32% | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack